Invokana Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Canagliflozin Targeting Vascular Inflammation
Conditions:   Diabetes Type 2;   Coronary Artery Disease Interventions:   Drug: Canagliflozin;   Drug: Placebo Sponsor:   Ottawa Heart Institute Research Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2022 Category: Research Source Type: clinical trials

Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease
Condition:   Type 2 Diabetes Mellitus With Complication Intervention:   Drug: Canagliflozin Sponsor:   First Affiliated Hospital Xi'an Jiaotong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2022 Category: Research Source Type: clinical trials